Your browser doesn't support javascript.
loading
Neural tube defects as a cause of death among stillbirths, infants, and children younger than 5 years in sub-Saharan Africa and southeast Asia: an analysis of the CHAMPS network.
Madrid, Lola; Vyas, Kartavya J; Kancherla, Vijaya; Leulseged, Haleluya; Suchdev, Parminder S; Bassat, Quique; Sow, Samba O; El Arifeen, Shams; Madhi, Shabir A; Onyango, Dickens; Ogbuanu, Ikechukwu; Scott, J Anthony G; Blau, Dianna; Mandomando, Inacio; Keita, Adama M; Gurley, Emily S; Mahtab, Sana; Akelo, Victor; Sannoh, Sulaiman; Tilahun, Yenenesh; Varo, Rosauro; Onwuchekwa, Uma; Rahman, Afruna; Adam, Yasmin; Omore, Richard; Lako, Sandra; Xerinda, Elisio; Islam, Kazi Munisul; Wise, Amy; Tippet-Barr, Beth A; Kaluma, Erick; Ajanovic, Sara; Kotloff, Karen L; Hossain, Mohammad Zahid; Mutevedzi, Portia; Tapia, Milagritos D; Rogena, Emily; Moses, Francis; Whitney, Cynthia G; Assefa, Nega.
Afiliação
  • Madrid L; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia. Electronic address: lola.madrid-castillo@lshtm.ac.uk.
  • Vyas KJ; Emory Global Health Institute, Emory University, Atlanta, GA, USA.
  • Kancherla V; Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Leulseged H; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Suchdev PS; Emory Global Health Institute, Emory University, Atlanta, GA, USA; Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Bassat Q; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; ICREA, Barcelona, Spain; Paediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain; Consorcio de Investigación
  • Sow SO; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • El Arifeen S; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
  • Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Onyango D; Kisumu County Department of Health, Kisumu, Kenya.
  • Ogbuanu I; Crown Agents, Freetown, Sierra Leone.
  • Scott JAG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Blau D; Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Mandomando I; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Instituto Nacional de Saúde, Maputo, Mozambique.
  • Keita AM; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Gurley ES; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Mahtab S; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Akelo V; US Centers for Disease Control and Prevention Kenya, Kisumu, Kenya.
  • Sannoh S; Crown Agents, Freetown, Sierra Leone.
  • Tilahun Y; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Varo R; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
  • Onwuchekwa U; Department of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Rahman A; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
  • Adam Y; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Omore R; Kisumu County Department of Health, Kisumu, Kenya.
  • Lako S; Crown Agents, Freetown, Sierra Leone.
  • Xerinda E; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
  • Islam KM; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
  • Wise A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Tippet-Barr BA; US Centers for Disease Control and Prevention Kenya, Kisumu, Kenya.
  • Kaluma E; Crown Agents, Freetown, Sierra Leone.
  • Ajanovic S; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
  • Kotloff KL; Department of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Hossain MZ; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
  • Mutevedzi P; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Tapia MD; Department of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Rogena E; Department of Pathology, School of Medicine, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
  • Moses F; Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Whitney CG; Emory Global Health Institute, Emory University, Atlanta, GA, USA.
  • Assefa N; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Lancet Glob Health ; 11(7): e1041-e1052, 2023 07.
Article em En | MEDLINE | ID: mdl-37271162
ABSTRACT

BACKGROUND:

Neural tube defects are common birth defects resulting in severe morbidity and mortality; they can largely be prevented with periconceptional maternal intake of folic acid. Understanding the occurrence of neural tube defects and their contribution to mortality in settings where their burden is highest could inform prevention and health-care policy. We aimed to estimate the mortality attributed to neural tube defects in seven countries in sub-Saharan Africa and southeast Asia.

METHODS:

This analysis used data from the Child Health and Mortality Prevention Surveillance (CHAMPS) network and health and demographic surveillance systems from South Africa, Mozambique, Bangladesh, Kenya, Mali, Ethiopia, and Sierra Leone. All stillbirths and infants and children younger than 5 years who died, who were enrolled in CHAMPS, whose families consented to post-mortem minimally invasive tissue sampling (MITS) between Jan 1, 2017, and Dec 31, 2021, and who were assigned a cause of death by a determination of cause of death panel as of May 24, 2022, were included in this analysis, regardless the cause of death. MITS and advanced diagnostic methods were used to describe the frequency and characteristics of neural tube defects among eligible deaths, identify risk factors, and estimate the mortality fraction and mortality rate (per 10 000 births) by CHAMPS site.

FINDINGS:

Causes of death were determined for 3232 stillbirths, infants, and children younger than 5 years, of whom 69 (2%) died with a neural tube defect. Most deaths with a neural tube defect were stillbirths (51 [74%]); 46 (67%) were neural tube defects incompatible with life (ie, anencephaly, craniorachischisis, or iniencephaly) and 22 (32%) were spina bifida. Deaths with a neural tube defect were more common in Ethiopia (adjusted odds ratio 8·09 [95% CI 2·84-23·02]), among female individuals (4·40 [2·44-7·93]), and among those whose mothers had no antenatal care (2·48 [1·12-5·51]). Ethiopia had the highest adjusted mortality fraction of deaths with neural tube defects (7·5% [6·7-8·4]) and the highest adjusted mortality rate attributed to neural tube defects (104·0 per 10 000 births [92·9-116·4]), 4-23 times greater than in any other site.

INTERPRETATION:

CHAMPS identified neural tube defects, a largely preventable condition, as a common cause of death among stillbirths and neonatal deaths, especially in Ethiopia. Implementing interventions such as mandatory folic acid fortification could reduce mortality due to neural tube defects.

FUNDING:

Bill & Melinda Gates Foundation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Natimorto / Defeitos do Tubo Neural Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Newborn / Pregnancy País como assunto: Africa / Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Natimorto / Defeitos do Tubo Neural Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Newborn / Pregnancy País como assunto: Africa / Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article